クリップ | Code No. | 品名 | データ | ||||
---|---|---|---|---|---|---|---|
データ
シート |
項目 | 標識 | MHC Allele | 包装 | 価格 | 在庫 | |
配列 | 位置 | 温度 | |||||
|
|||||||
SPC004 |
SARS-CoV-2 envelope protein (56-70) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
FYVYSRVKNLNSSRV | 56-70 | -20°C | |||||
SPC032 |
Chain A, SARS-CoV-2 spike glycoprotein (539-546) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
VNFNFNGL | 539-546 | -20°C | |||||
SPC048 |
SARS-CoV-2 envelope protein (21-35) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
LAFVVFLLVTLAILT | 21-35 | -20°C | |||||
TB-M047-2 |
HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLPQLCTEL | 18-26 | 4°C | |||||
SPC012 |
SARS-CoV-2 chain A spike glycoprotein (236-250) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
TRFQTLLALHRSYLT | 236-250 | -20°C | |||||
TS-M501-1 |
T-Select H-2Kb β-galactosidase Tetramer-DAPIYTNV-PE |
||||||
bacteria | PE | H-2Kb | 50 tests | ¥209,000 | 1-9 | ||
DAPIYTNV | 96-103 | 4°C | |||||
SPC035 |
Chain A, SARS-CoV-2 spike glycoprotein (511-518) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
VVLSFELL | 511-518 | -20°C | |||||
SPC043 |
ORF1ab polyprotein SARS-CoV-2 (5573-5580) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
ITGLYPTL | 5573-5580 | -20°C | |||||
SPC038 |
Chain A, SARS-CoV-2 spike glycoprotein (1060-1068) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
VVFLHVTYV | 1060-1068 | -20°C | |||||
SPC023 |
SARS-CoV-2 ORF3a protein (107-115) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
YLYALVYFL | 107-115 | -20°C | |||||
TB-5001-4 |
T-Select H-2Kb OVA Tetramer-SIINFEKL-BV421 |
||||||
OVA | BV421 | H-2Kb | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SIINFEKL | 257-264 | 4°C | |||||
SPC052 |
SARS-CoV-2 chain A spike glycoprotein (51-65) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
TQDLFLPFFSNVTWF | 51-65 | -20°C | |||||
SPC037 |
Chain A, SARS-CoV-2 spike glycoprotein (447-455) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
GNYNYLYRL | 447-455 | -20°C | |||||
SPC024 |
SARS-CoV-2 ORF1ab (2192-2200) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
ASMPTTIAK | 2192-2200 | -20°C | |||||
SPC050 |
SARS-CoV-2 membrane glycoprotein (41-55) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
NRNRFLYIIKLIFLW | 41-55 | -20°C | |||||
SPC041 |
ORF1ab polyprotein SARS-CoV-2 (5385-5393) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
VTQLYLGGM | 5385-5393 | -20°C | |||||
SPC006 |
SARS-CoV-2 nucleocapsid phosphoprotein (221-235) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
LLLLDRLNQLESKMS | 221-235 | -20°C | |||||
SPC020 |
SARS-CoV-2 ORF1ab (3710-3718) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
TLMNVLTLV | 3710-3718 | -20°C | |||||
SPC007 |
SARS-CoV-2 membrane glycoprotein (176-190) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
LSYYKLGASQRVAGD | 176-190 | -20°C | |||||
SPC014 |
SARS-CoV-2 ORF3a protein (206-220) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
YFTSDYYQLYSTQLS | 206-220 | -20°C | |||||
SPC030 |
SARS-CoV-2 ORF1ab (4986-4994) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
FYGGWHNML | 4986-4994 | -20°C | |||||
SPC039 |
Chain A, SARS-CoV-2 spike glycoprotein (691-699) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
SIIAYTMSL | 691-699 | -20°C | |||||
SPC021 |
SARS-CoV-2 ORF1ab (6419-6427) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
YLDAYNMMI | 6419-6427 | -20°C | |||||
SPC029 |
SARS-CoV-2 ORF1ab (6159-6167) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
DYVYNPFMI | 6159-6167 | -20°C | |||||
SPC049 |
SARS-CoV-2 ORF7a protein (1-15) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
MKIILFLALITLATC | 1-15 | -20°C | |||||
SPC027 |
SARS-CoV-2 ORF1ab (2600-2608) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
STFNVPMEK | 2600-2608 | -20°C | |||||
SPC045 |
Chain A, SARS-CoV-2 spike glycoprotein (449-456) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
YNYLYRLF | 449-456 | -20°C | |||||
SPC009 |
SARS-CoV-2 membrane glycoprotein (91-105) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
MWLSYFIASFRLFAR | 91-105 | -20°C | |||||
SPC010 |
SARS-CoV-2 ORF1ab polyprotein (5016-5030) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
RAMPNMLRIMASLVL | 5016-5030 | -20°C | |||||
SPC040 |
Chain A, SARS-CoV-2 spike glycoprotein (424-433) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
KLPDDFTGCV | 424-433 | -20°C | |||||
SPC022 |
SARS-CoV-2 ORF1ab (6851-6859) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
YLNTLTLAV | 6851-6859 | -20°C | |||||
SPC015 |
SARS-CoV-2 ORF1ab (3122-3130) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
FLAHIQWMV | 3122-3130 | -20°C | |||||
SPC002 |
SARS-CoV-2 ORF1ab polyprotein (471-485) peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
EEIAIILASFSASTS | 471-485 | -20°C | |||||
SPC008 |
SARS-CoV-2 ORF3a protein (1-15) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
MDLFMRIFTIGTVTL | 1-15 | -20°C | |||||
SPC026 |
SARS-CoV-2 nucleocapsid phosphoprotein (362-370) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
KTFPPTEPK | 362-370 | -20°C | |||||
TS-M018-1 |
T-Select HLA-A*24:02 HTLV-1 Tax301-309 Tetramer-SFHSLHLLF-PE |
||||||
virus | PE | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SFHSLHLLF | 301-309 | 4°C | |||||
SPC003 |
SARS-CoV-2 ORF1ab polyprotein (1801-1815) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
ESPFVMMSAPPAQYE | 1801-1815 | -20°C | |||||
SPC033 |
Chain A, SARS-CoV-2 spike glycoprotein (902-909) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
MAYRFNGI | 902-909 | -20°C | |||||
SPC046 |
SARS-CoV-2 chain A spike glycoprotein (363-377) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
ADYSVLYNSASFSTF | 363-377 | -20°C | |||||
SPC001 |
SARS-CoV-2 ORF1ab polyprotein (3906-3920) peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
EAFEKMVSLLSVLLS | 3906-3920 | -20°C | |||||
TS-M516-1 |
T-Select H-2Dd HIV P18-I10 Tetramer-RGPGRAFVTI-PE |
||||||
virus | PE | H-2Dd | 50 tests | ¥209,000 |
0 (お問合せ) |
||
RGPGRAFVTI | 318-327 | 4°C | |||||
SPC044 |
Chain A, SARS-CoV-2 spike glycoprotein (263-270) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
AAYYVGYL | 263-270 | -20°C | |||||
SPC016 |
SARS-CoV-2 ORF1ab (3183-3191) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
FLLNKEMYL | 3183-3191 | -20°C | |||||
SPC013 |
SARS-CoV-2 nucleocapsid phosphoprotein (301-315) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
WPQIAQFAPSASAFF | 301-315 | -20°C | |||||
SPC031 |
SARS-CoV-2 ORF1ab (3159-3167) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
NYLKRRVVF | 3159-3167 | -20°C | |||||
SPC036 |
Chain A, SARS-CoV-2 spike glycoprotein (325-332) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
SIVRFPNI | 325-332 | -20°C | |||||
SPC051 |
SARS-CoV-2 chain A spike glycoprotein (509-523) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
RVVVLSFELLHAPAT | 509-523 | -20°C | |||||
SPC011 |
SARS-CoV-2 ORF1ab polyprotein (3946-3960) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
SEFSSLPSYAAFATA | 3946-3960 | -20°C | |||||
SPC028 |
SARS-CoV-2 ORF1ab (1875-1883) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
TTIKPVTYK | 1875-1883 | -20°C | |||||
SPC019 |
SARS-CoV-2 ORF1ab (3732-3740) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
SMWALIISV | 3732-3740 | -20°C | |||||
SPC034 |
Chain A, SARS-CoV-2 spike glycoprotein (233-241) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
INITRFQTL | 233-241 | -20°C | |||||
SPC005 |
SARS-CoV-2 ORF1ab polyprotein (2211-2225) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
LEASFNYLKSPNFSK | 2211-2225 | -20°C | |||||
SPC017 |
SARS-CoV-2 ORF1ab (6749-6758) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
LLLDDFVEII | 6749-6758 | -20°C | |||||
SPC025 |
SARS-CoV-2 ORF1ab (4892-4900) Peptide |
||||||
virus | 1 mg | ¥25,000 |
0 (お問合せ) |
||||
KSAGFPFNK | 4892-4900 | -20°C | |||||
TS-M014-2 |
T-Select HLA-A*24:02 modified WT1 Tetramer-CYTWNQMNL-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥209,000 | 1-9 | ||
CYTWNQMNL | 235-243 | 4°C | |||||
TS-M523-1 |
T-Select H-2Kb HSV-1 gB Tetramer-SSIEFARL-PE |
||||||
virus | PE | H-2Kb | 50 tests | ¥209,000 | 1-9 | ||
SSIEFARL | 498-505 | 4°C | |||||
TS-M526-1 |
T-Select H-2Kd HER2 Tetramer-TYLPTNASL-PE |
||||||
cancer | PE | H-2Kd | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TYLPTNASL | 63-71 | 4°C | |||||
TB-5113-1 |
H-2Db Adpgk Neoepitope Tetramer-ASMTNMELM-PE |
||||||
cancer | PE | H-2Db | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ASMTNMELM | 4°C | ||||||
TS-M545-1 |
H-2Kd Erk2 K136Q Tetramer-QYIHSANVL-PE |
||||||
cancer | PE | H-2Kd | 50 tests | ¥209,000 |
0 (お問合せ) |
||
QYIHSANVL | 136-144 | 4°C | |||||
TS-M515-1 |
T-Select H-2Kd malaria Pb9 Tetramer-SYIPSAEKI-PE |
||||||
bacteria | PE | H-2Kd | 50 tests | ¥209,000 | 1-9 | ||
SYIPSAEKI | 252-260 | 4°C | |||||
TS-M555-1 |
H-2Kd RSV F glycoprotein Tetramer-KYKNAVTEL-PE |
||||||
virus | PE | H-2Kd | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KYKNAVTEL | 85-93 | 4°C | |||||
TS-M151-3 |
HLA-A*02:01 Control Tetramer-ALAAAAAAV-FITC |
||||||
negative | FITC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ALAAAAAAV | 4°C | ||||||
TB-M534-1 |
H-2Kd Influenza NP Tetramer-TYQRTRALV-PE |
||||||
virus Influenza |
PE | H-2Kd | 50 tests | ¥190,000 |
0 (お問合せ) |
||
TYQRTRALV | 147-155 | 4°C | |||||
TS-M525-1 |
T-Select H-2Kd EGFP Tetramer-HYLSTQSAL-PE |
||||||
Others | PE | H-2Kd | 50 tests | ¥209,000 |
0 (お問合せ) |
||
HYLSTQSAL | 200-208 | 4°C | |||||
TB-0113-2 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLFFYRKSV | 4°C | ||||||
TB-M057-1 |
HLA-A*02:01 CMV IE1 316-324 Tetramer-VLEETSVML-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLEETSVML | 316-324 | 4°C | |||||
TB-5002-4 |
T-Select H-2Db LCMV gp33 Tetramer-KAVYNFATC-BV421 |
||||||
virus LCMV |
BV421 | H-2Db | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KAVYNFATC | 33-41 | 4°C | |||||
TS-M151-1 |
HLA-A*02:01 Control Tetramer-ALAAAAAAV-PE |
||||||
negative | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
ALAAAAAAV | 4°C | ||||||
TB-0025-2 |
T-Select HLA-B*07:02 CMV pp65 Tetramer-TPRVTGGGAM-APC |
||||||
virus CMV |
APC | B*07:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
TPRVTGGGAM | 417-426 | 4°C | |||||
TB-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RMPEAAPPV | 65-73 | 4°C | |||||
TS-M546-2 |
H-2Db gp100 Tetramer-EGSRNQDWL-APC |
||||||
cancer | APC | H-2Db | 50 tests | ¥209,000 | 1-9 | ||
EGSRNQDWL | 25-33 | 4°C | |||||
TS-M151-2 |
HLA-A*02:01 Control Tetramer-ALAAAAAAV-APC |
||||||
negative | APC | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
ALAAAAAAV | 4°C | ||||||
TB-5106-1 |
Qa-1b CD94/NKG2 Qdm Tetramer-AMAPRTLLL-PE |
||||||
nonclassical MHC | PE | Qa-1b | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AMAPRTLLL | 4°C | ||||||
TS-M016-2 |
T-Select HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
RMFPNAPYL | 126-134 | 4°C | |||||
TB-0148-4 |
HLA-B*27:05 HIV env Tetramer-GRAFVTIGK-BV421 |
||||||
virus HIV |
BV421 | B*27:05 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GRAFVTIGK | 103-111 | 4°C | |||||
TS-M719-1 |
T-Select I-Ab Mtb Ag85B240-254 Tetramer-PE |
||||||
Others | PE | I-Ab | 20 tests | ¥198,000 |
0 (お問合せ) |
||
FQDAYNAAGGHNAVF | 240-254 | 4°C | |||||
TS-M152-1 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-PE |
||||||
negative | PE | A*11:01 | 50 tests | ¥209,000 | 1-9 | ||
ATAAAAAAK | 4°C | ||||||
TS-M077-2 |
HLA-A*24:02 MAGE-A3 Tetramer-IMPKAGLLI-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
IMPKAGLLI | 195-203 | 4°C | |||||
TB-5004-4 |
T-Select H-2Kb TRP-2 Tetramer-SVYDFFVWL-BV421 |
||||||
cancer | BV421 | H-2Kb | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SVYDFFVWL | 180-188 | 4°C | |||||
TB-M524-4 |
T-Select H-2Db HY Uty Tetramer-WMHHNMDLI-BV421 |
||||||
Others | BV421 | H-2Db | 50 tests | ¥190,000 |
0 (お問合せ) |
||
WMHHNMDLI | 246-254 | 4°C | |||||
TB-0012-4 |
T-Select HLA-A*02:01 Influenza-M1 Tetramer-GILGFVFTL-BV421 |
||||||
virus Influenza |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GILGFVFTL | 58-66 | 4°C | |||||
TS-M018-2 |
T-Select HLA-A*24:02 HTLV-1 Tax301-309 Tetramer-SFHSLHLLF-APC |
||||||
virus | APC | A*24:02 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
SFHSLHLLF | 301-309 | 4°C | |||||
TS-M501-2 |
T-Select H-2Kb β-galactosidase Tetramer-DAPIYTNV-APC |
||||||
bacteria | APC | H-2Kb | 50 tests | ¥209,000 | 1-9 | ||
DAPIYTNV | 96-103 | 4°C | |||||
TS-M509-1 |
T-Select H-2Kb SeV Tetramer-FAPGNYPAL-PE |
||||||
virus | PE | H-2Kb | 50 tests | ¥209,000 |
0 (お問合せ) |
||
FAPGNYPAL | 324-332 | 4°C | |||||
TB-M075-1 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KVAELVHFL | 112-120 | 4°C | |||||
TB-5114-2 |
H-2Db REPS1 Neoepitope Tetramer-AQLANDVVL-APC |
||||||
cancer | APC | H-2Db | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AQLANDVVL | 4°C | ||||||
TB-5102-2 |
H-2Kb Survivin Tetramer-MFFCFKEL-APC |
||||||
cancer | APC | H-2Kb | 50 tests | ¥190,000 |
0 (お問合せ) |
||
MFFCFKEL | 4°C | ||||||
TB-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
||||||
cancer | PE | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RYCNLEGPPI | 177-186 | 4°C | |||||
TS-M517-1 |
T-Select H-2Dd BCG MPT51 Tetramer-GGPHAVYLL-PE |
||||||
bacteria | PE | H-2Dd | 50 tests | ¥209,000 |
0 (お問合せ) |
||
GGPHAVYLL | 24-32 | 4°C | |||||
TB-0029-2 |
T-Select HLA-A*02:01 Negative Tetramer-APC |
||||||
negative | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
4°C | |||||||
TS-M152-2 |
HLA-A*11:01 Control Tetramer-ATAAAAAAK-APC |
||||||
negative | APC | A*11:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ATAAAAAAK | 4°C | ||||||
TB-M524-2 |
T-Select H-2Db HY Uty Tetramer-WMHHNMDLI-APC |
||||||
Others | APC | H-2Db | 50 tests | ¥190,000 |
0 (お問合せ) |
||
WMHHNMDLI | 246-254 | 4°C | |||||
TS-M094-1 |
HLA-A*02:01 H-Y Tetramer-FIDSYICQV-PE |
||||||
Others | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
FIDSYICQV | 311-319 | 4°C | |||||
TB-5113-2 |
H-2Db Adpgk Neoepitope Tetramer-ASMTNMELM-APC |
||||||
cancer | APC | H-2Db | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ASMTNMELM | 4°C | ||||||
TS-TCR01-1 |
Human TCR Tetramer-PE (HLA-A*24:02 survivin-2B80-88-AYACNTSTL) |
||||||
cancer | PE | 50 tests | ¥275,000 |
0 (お問合せ) |
|||
4°C | |||||||
TB-M513-4 |
T-Select H-2Db LCMV NP369 Tetramer-FQPQNGQFI-BV421 |
||||||
virus LCMV |
BV421 | H-2Db | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FQPQNGQFI | 369-404 | 4°C | |||||
TB-0140-2 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-APC |
||||||
cancer | APC | A*24:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
EYILSLEEL | 298-306 | 4°C | |||||
TS-M535-2 |
H-2Kd Influenza HA Tetramer-LYQNVGTYV-APC |
||||||
virus | APC | H-2Kd | 50 tests | ¥209,000 | 1-9 | ||
LYQNVGTYV | 204-212 | 4°C | |||||
TB-M011-4 |
T-Select HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLMWITQC | 157-165 | 4°C | |||||
TB-0025-4 |
T-Select HLA-B*07:02 CMV pp65 Tetramer-TPRVTGGGAM-BV421 |
||||||
virus CMV |
BV421 | B*07:02 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
TPRVTGGGAM | 417-426 | 4°C |
※在庫につきましては2024年07月03日 00時05分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、
キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について: RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。